Alpha, Sharima .

HRN: 07-33-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 750MG (VIAL)
06/23/2025
06/30/2025
IV
600mg
Q8
UTI
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractBloodstreamProphylaxis    Compliance to guidelines: